Target intelligence / Profile preview

Plasma membrane electron transport chain (PMET)

Target
PMET
Molecular classification
Other (not a classical receptor, transporter, enzyme, or transcription factor), In some contexts, relates to enzyme complexes or oxidoreductases embedded in the plasma membrane
01

Overview

In general biology, the plasma membrane electron transport chain refers to a set of enzymes and carriers present in the plasma membrane that facilitate the transfer of electrons across the cell membrane. This process is prominent in prokaryotes (where the plasma membrane is the main site of electron transport driving ATP synthesis) and in the thylakoid membranes of plants. In mammalian cells, most electron transport for energy metabolism occurs in the mitochondrial inner membrane[8][3]. However, plasma membrane redox systems or “extramitochondrial electron transport systems” have been described as contributors to redox balance, cellular signaling, and antioxidant defense mechanisms at the cell surface, but these systems are less well defined, less studied, and not usually major therapeutic targets[8][3]. If you intended to refer specifically to the mitochondrial electron transport chain, a correction is needed, as the canonical electron transport chain in animals is mitochondrial, not plasma membrane-associated[8][3].

Other names
Plasma membrane electron transport systemPlasma membrane redox systemExtramitochondrial electron transport chainPMET (in some literature)
02

Mechanism of action

Not applicable; no approved drugs with established PMET mechanism.

03

Biological functions

Redox balanceCellular antioxidant defenseMaintenance of plasma membrane potentialTrans-plasma membrane electron transfer (mainly in microbes or plants; marginal in animals)
04

Disease associations

OtherPotentially in cancer cell metabolism (cancer cells may upregulate extracellular electron transfer)Roles in microbial infection and pathogenesis (for microbes with PMETs)
05

Safety considerations

No established therapeutic safety concerns directly related to plasma membrane electron transport chains, as these are not a major drug target.
06

Interacting drugs

There are no established, approved drugs that directly target a well-defined “plasma membrane electron transport chain” in humans. Some experimental redox modulators, or quinones, might interact with plasma membrane redox systems in specialized research settings.
07

Biomarkers

None established for clinical use. Experimental markers may include assays for surface NAD(P)H oxidase activity or redox capacity in research.

Beyond the preview

Go deeper on Plasma membrane electron transport chain (PMET).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma membrane electron transport chain (PMET).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call